Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
瑋 俊 生 物 科 技 有 限 公 司
Wai Chun Bio-Technology Limited
(Incorporated in Cayman Islands with limited liabilities)
Stock code 0660
RESIGNATION OF CHIEF FINANCIAL(OFFICER,:)COMPANY SECRETARY
AND AUTHORISED REPRESENTATIVE
Reference is made to the announcement of Wai Chun Bio-Technology Limited (the "Company") dated 30 April 2021 in connection with the resignation of Chief Financial Officer, Company Secretary and Authorised Representative. Capitalised terms used herein shall have the same meaning as those defined in the Announcement unless stated otherwise.
The board of directors ("the Board") of the Company announces that, with effect from 30 April 2021, Mr. Chiu Chun Tak ("Mr. Chiu") resigned as the Chief Financial Officer, Company Secretary and Authorised Representative of the Company as Mr. Chiu would like to devote more time for his career development.
Mr. Chiu has confirmed that he has no disagreement with the Board and there is no matter relating to his resignation that should be brought to the attention of the shareholders of the Company and The
Stock Exchange of Hong Kong Limited.
The Company is in the process of identifying a suitable candidate to fill the vacancy of Chief Financial Officer, Company Secretary and Authorised Representative caused by the resignation of Mr. Chiu, and will publish further announcement once such appointment is confirmed.
The Board would like to extend its appreciation to Mr. Chiu for his valuable contributions to the Company during his tenure of service.
1
By Order of the Board
Wai Chun Bio-Technology Limited
Lam Ching Kui
Chairman and Chief Executive Officer
Hong Kong, 4 May 2021
As at the date of this announcement, the Board comprises:
Executive Director:
LAM Ching Kui (Chairman and Chief Executive Officer)
Independent Non-executive Directors:
CHAN Cheuk Ho
WAN Bo
HAU Pak Man
2
Attachments
- Original document
- Permalink
Disclaimer
Wai Chun Bio Technology Ltd. published this content on 04 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 May 2021 11:48:11 UTC.